These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3039218)

  • 1. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
    Nishimura K; Miyazaki M; Okunishi H; Toda N
    Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
    Nakata K; Nishimura K; Takada T; Ikuse T; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):305-10. PubMed ID: 2437397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive mechanism of an angiotensin converting enzyme inhibitor, SA446, in dogs.
    Nishimura K; Okunishi H; Miyazaki M
    Bull Osaka Med Coll; 1989 Nov; 35(1-2):29-37. PubMed ID: 2486241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
    Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
    Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
    Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species difference of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinec arb oxylic acid (SA446) in inhibition of angiotensin converting enzyme.
    Nakata K; Iwatani T; Horiuchi M; Kito H; Yamauchi H; Iso T
    Jpn J Pharmacol; 1986 Mar; 40(3):367-72. PubMed ID: 3012163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
    Nakata K; Takada T; Yamauchi H; Iso T
    Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated vascular angiotensin converting enzyme in chronic two-kidney, one clip hypertension in the dog.
    Miyazaki M; Okunishi H; Okamura T; Toda N
    J Hypertens; 1987 Apr; 5(2):155-60. PubMed ID: 3038993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
    Komori T; Takada T; Funae Y; Yamamoto K
    Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats.
    Komori T; Yamamoto K
    Jpn J Pharmacol; 1981 Jun; 31(3):401-7. PubMed ID: 6273629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between the inhibition of renin-angiotensin system and antihypertensive effect of MK-421 and captopril in 2-kidney, 1-clip renal hypertensive rats after single and repeated oral administration of MK-421 or captopril].
    Ohmura I; Maki E; Naruse T; Ikeda N; Asami T; Sagawa N
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):303-13. PubMed ID: 3002926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall.
    Okunishi H; Miyazaki M; Toda N
    J Hypertens; 1984 Jun; 2(3):277-84. PubMed ID: 6099388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment].
    Nakata K; Nishimura K; Takada T; Yamauchi H; Iso T
    Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):113-21. PubMed ID: 3699625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
    Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
    Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors.
    Tokita Y; Oda H; Franco-Saenz R; Mulrow PJ
    Proc Soc Exp Biol Med; 1995 Apr; 208(4):391-6. PubMed ID: 7700888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration].
    Takada T; Nakata K; Yamauchi H; Iso T
    Nihon Yakurigaku Zasshi; 1986 Mar; 87(3):331-7. PubMed ID: 3710315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats.
    Unger T; Rockhold RW; Schaz K; Vescel P; Bönner G; Rascher W; Ganten D
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():157s-160s. PubMed ID: 232020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.